In:
Genome Research, Cold Spring Harbor Laboratory, Vol. 22, No. 2 ( 2012-02), p. 188-195
Kurzfassung:
The genomics era has yielded great advances in the understanding of cancer biology. At the same time, the immense complexity of the cancer genome has been revealed, as well as a striking heterogeneity at the whole-genome (or omics) level that exists between even histologically similar tumors. The vast accrual and public availability of multi-omics databases with associated clinical annotation including tumor histology, patient response, and outcome are a rich resource that has the potential to lead to rapid translation of high-throughput omics to improved overall survival. We focus on the unique advantages of a multidimensional approach to genomic analysis in this new high-throughput omics age and discuss the implications of the changing cancer demographic to translational omics research.
Materialart:
Online-Ressource
ISSN:
1088-9051
DOI:
10.1101/gr.124354.111
Sprache:
Englisch
Verlag:
Cold Spring Harbor Laboratory
Publikationsdatum:
2012
ZDB Id:
1483456-X
SSG:
12
Permalink
